T. Klenner

Ether–lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether–lipid analogues in Leishmania

H. Lux, Norton Heise, T. Klenner et al. · Molecular and Biochemical Parasitology · 2000 · 152 citations

Ether–lipid Analogues, Biochemistry, Parasitic Protozoa +4

D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity.

Gerald Bacher, B Nickel, Peter Emig et al. · PubMed · 2001 · 142 citations

Tumor Biology, Oncology, Medicine +13

Interleukin 3 Improves the Ex Vivo Expansion of Primitive Human Cord Blood Progenitor Cells and Maintains the Engraftment Potential of SCID Repopulating Cells

T. Roβmanith, Bernd Schröder, Gesine Bug et al. · Stem Cells · 2001 · 65 citations · Full text

Ex Vivo Expansion, Cell Therapy, Immunology +19

Anticancer-agent-linked phosphonates with antiosteolytic and antineoplastic properties: a promising perspective in the treatment of bone-related malignancies?

T. Klenner, F. Wingen, Bernhard K. Keppler et al. · Journal of Cancer Research and Clinical Oncology · 1990 · 59 citations · Full text

Bone Disease, Medicinal Chemistry, Oncology +12

Topical treatment with hexadecylphosphocholine (Miltex®) efficiently reduces parasite burden in experimental cutaneous leishmaniasis

Ruprecht Schmidt‐Ott, T. Klenner, Peter Overath et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 1999 · 57 citations

Parasite Burden, Murine Visceral Leishmaniasis, Antiparasitic Agent +15